SAP ace: donated 3 million yuan for flood control and disaster relief in Zhengzhou and other places
Shapeis announced that the company has donated a total of 3 million yuan to the Red Cross Society of China, the Red Cross Society of Henan Province and the Red Cross Society of Zhengzhou City for flood control and disaster relief, health and epidemic prevention and post disaster reconstruction in Zhengzhou and other disaster areas.
This text is a result of machine translation.
Related companies：
Briefing Jun 27, 2022 02:19 PM
· Technology
Special representative of the Russian President: Russia will realize technological sovereignty within 10 to 20 years
In-depth
Technology
Apple and China: A Mutually Beneficial Relationship
In 2019, around 46% of Apple's suppliers were Chinese companies or China-based factories. Not only do Chinese firms rely on Apple's sizable orders, but Apple also sees benefits from the country’s high cost-efficiency and growing innovation.
Aug 24, 2020 12:11 AM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Jun 22, 2022 11:50 AM
Three departments: incorporate the construction of public fitness facilities in rural areas into the five-year action plan for building fitness facilities in various regions
Briefing Jun 22, 2022 10:50 AM
Goethe shares flash crash limit Securities Department: the company's operation is stable, and the expectation for the second quarter has not been adjusted
Healthcare
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Briefing Jun 13, 2022 09:44 AM
· Healthcare
Cro plate fell, and Wuxi apptec fell nearly 10%
Healthcare
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Mar 31, 2021 11:38 AM
Briefing Jun 01, 2022 09:23 AM
· Financials
American officials: the United States plans to expand its diplomatic presence in the Indian Pacific Region
Briefing May 21, 2022 06:44 AM
· Financials
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
See more
Read next
Insight
In-depth
Insight
In-depth